Catalyst Wire Dossier Catalyst Wire Dossier

Atropine Sulfate Eye Drops 0.01%

atropine sulfate · Ocumension Therapeutics (Suzhou) Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Atropine Sulfate Eye Drops 0.01%, covering 2024-11-20 to 2024-11-20. Get the full timeline:

Most recent: Clinical Trial Update: Study of Atropine Sulfate Eye Drops(0.01%) in Treating Near-work-induced Transient Myopia in Children [Phase 3]

See pricing